🇺🇸 FDA
Patent

US 8173664

Modified pyrimidine glucocorticoid receptor modulators

granted A61KA61K31/506A61K31/513

Quick answer

US patent 8173664 (Modified pyrimidine glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/506, A61K31/513, A61K31/551, A61P